Ligand Pharmaceuticals LGND Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's common stock, shares issued (in shares)?
- Ligand Pharmaceuticals (LGND) reported common stock, shares issued (in shares) of $20.03M in Q1 2026.
- How has Ligand Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
- Ligand Pharmaceuticals's common stock, shares issued (in shares) increased by 3.9% year-over-year, from $19.28M to $20.03M.
- What is the long-term trend for Ligand Pharmaceuticals's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's common stock, shares issued (in shares) has grown at a 4.2% compound annual growth rate (CAGR), from $16.08M to $19.77M.